Le Lézard
Classified in: Science and technology
Subjects: Conference, Event

Majesco Announces Fall Product Council to be held in Bridgewater, New Jersey, November 12, 2019


Majesco (NASDAQ: MJCO), a global leader of cloud insurance software solutions for insurance business transformation, today announced that it will host its 12th Product Council meeting November 12 in Bridgewater, New Jersey. Majesco hosts the Product Council twice a year in the spring and fall.

"As a leading insurance product company, we value the input from our customers for shaping the roadmap of our products. Our semi-annual product council is a great way to bring together our customers, product management and leadership to collaborate on the roadmap by keeping our customers' needs at the core," commented Manish Shah, President and Chief Product Officer at Majesco. "With our market leading monthly automated updates of our software products along with regulatory updates for rates, rules and forms, our roadmap is a "living" guide for our development teams and our customers, providing them details to help shape their plans.

Opening the Product Council meeting will be CEO Adam Elster and Chief Product Officer Manish Shah, providing an update on the company as well as the recent market availability of Version 11 of Majesco P&C Core Suite and Majesco L&A and Group Core Suite. The day will be spent in breakout sessions for each of the software solutions to review, discuss and collaborate on the 2020 product roadmap priorities.

"We are excited and honored to have such a diverse and active customer base who participate not just in our Product Council, but daily in their submission of ideas that continue to strengthen and innovate our solutions to meet the demands of a fast-changing insurance marketplace," stated Adam Elster, CEO of Majesco. "Together, we are creating the future of insurance that is connecting customers to insurance in ways that are innovative, hyper-relevant, compelling and personal."

About Majesco

Majesco (NASDAQ: MJCO) provides technology, expertise, and leadership that helps insurers modernize, innovate and connect to build the future of their business ? and the future of insurance ? at speed and scale. Our platforms connect people and businesses to insurance in ways that are innovative, hyper-relevant, compelling and personal. Over 200 insurance companies worldwide in P&C, L&A and Group Benefits are transforming their businesses by modernizing, optimizing or creating new business models with Majesco. Our market-leading solutions include CloudInsurer® P&C Core Suite (Policy, Billing, Claims); CloudInsurer® L&A and Group Core Suite (Policy, Billing, Claims); Digital1st Insurancetm with Digital1st eConnecttm, Digital1st EcoExchangetm and Digital1st Platformtm ? a cloud-native, microservices and open API platform; Distribution Management, Data and Analytics and an Enterprise Data Warehouse. For more details on Majesco, please visit www.majesco.com.

Cautionary Language Concerning Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of management, are not guarantees of performance and are subject to significant risks and uncertainty. These forward-looking statements should, therefore, be considered in light of various important factors, including those set forth in Majesco's reports that it files from time to time with the Securities and Exchange Commission and which you should review, including those statements under "Item 1A ? Risk Factors" in Majesco's Annual Report on Form 10-K.

Important factors that could cause actual results to differ materially from those described in forward-looking statements contained in this press release include, but are not limited to: integration risks; changes in economic conditions, political conditions, trade protection measures, licensing requirements and tax matters; technology development risks; intellectual property rights risks; competition risks; additional scrutiny and increased expenses as a result of being a public company; the financial condition, financing requirements, prospects and cash flow of Majesco; loss of strategic relationships; changes in laws or regulations affecting the insurance industry in particular; restrictions on immigration; the ability and cost of retaining and recruiting key personnel; the ability to attract new clients and retain them and the risk of loss of large customers; continued compliance with evolving laws; customer data and cybersecurity risk; and Majesco's ability to raise capital to fund future growth.

These forward-looking statements should not be relied upon as predictions of future events and Majesco cannot assure you that the events or circumstances discussed or reflected in these statements will be achieved or will occur. If such forward-looking statements prove to be inaccurate, the inaccuracy may be material. You should not regard these statements as a representation or warranty by Majesco or any other person that we will achieve our objectives and plans in any specified timeframe, or at all. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this presentation. Majesco disclaims any obligation to publicly update or release any revisions to these forward-looking statements, whether as a result of new information, future events or otherwise, after the date of this press release or to reflect the occurrence of unanticipated events, except as required by law.


These press releases may also interest you

at 16:35
AVROBIO, Inc. , a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today shared an update on its response to the COVID-19 pandemic and a current assessment of the impact on AVROBIO's...

at 16:30
An economic crisis can strike anytime, and the latest black swan event that we've entered is the best proof. Such an unpredictable and unforeseen event, unfortunately, comes with some extreme consequences, and people have to prepare for bleak times....

at 16:30
NeuroBo Pharmaceuticals, Inc. , a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying therapies for neurodegenerative and cardiometabolic diseases, today announced financial results for the...

at 16:25
Canon U.S.A., Inc., a leader in digital imaging solutions, announced today that they will be hosting a Virtual Press Conference to unveil the company's new professional imaging products and technologies. The Virtual Press Conference, which will be...

at 16:15
QSC announces the opening of QSC Netherlands BV, effective April 1, 2020. Based in Geldermalsen, QSC Netherlands BV will serve as the business development hub for Live Sound & Systems in the Benelux region as well as house QSC's EMEA service repair...

at 16:15
INVO Bioscience, Inc. , a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world's only in vivo Intravaginal Culture System, today announced financial results...



News published on 7 november 2019 at 16:35 and distributed by: